Table 1. Members of SLE Quality Indicators Project Advisory Panel and RAND/UCLA Appropriateness Method Expert Panel.
SLE QI Project Advisory Panel | Primary Practice Setting |
---|---|
Moderator | |
David Wofsy, MD | University of California, San Francisco |
Panelists | |
Eliza Chakravarty, MD, MSc | Stanford University |
Maria Dall'Era, MD | University of California, San Francisco |
James Davis, MD* | Sutter Health, San Francisco |
John C. Davis, Jr., MD, MPH† | University of California, San Francisco |
Kenneth Kalunian, MD | University of California, San Diego |
Nina D. Schwartz, MD | Kaiser Permanente, South San Francisco |
Daniel J. Wallace, MD | David Geffen School of Medicine at UCLA |
Michael M. Ward, MD | NIH/NIAMS |
SLE QI Project RAND/UCLA Appropriateness Method Panel | |
Moderator | |
Catherine MacLean, MD, PhD‡ | University of California, Los Angeles |
Panelists | |
Rashmi B. Dixit, MD, PhD | Walnut Creek, California |
Richard Furie, MD | North Shore-Long Island Jewish Health System |
Jennifer Grossman, MD | David Geffen School of Medicine at UCLA |
Lester Miller, MD | Santa Cruz, California |
Rosalind Ramsey-Goldman, MD, DrPh | Feinberg School of Medicine, Northwestern University |
Brad Rovin, MD* | Ohio State University |
Kenneth Saag, MD | University of Alabama at Birmingham |
Jorge Sanchez-Guerrero, MD, MS | National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico |
David Wofsy, MD | University of California, San Francisco |
James Davis practices Internal Medicine and Rheumatology. Brad Rovin is a nephrologist. All others primarily practice Rheumatology.
John C. Davis, Jr. is currently employed at Genentech, Inc. He was employed at the University of California, San Francisco when asked to sit on the panel.
Catherine MacLean is also Director of Programs in Clinical Excellence at Wellpoint, Inc.